Close X
Tuesday, December 3, 2024
ADVT 
National

Monkeypox poses low risk, but everyone susceptible

Darpan News Desk The Canadian Press, 20 May, 2022 11:44 AM
  • Monkeypox poses low risk, but everyone susceptible

OTTAWA - Canada's top public health officials say the risk posed by monkeypox is low, but nearly everyone in the country is susceptible because routine vaccination against smallpox ended decades ago.

The first two cases of the virus in Canada were confirmed in Quebec on Thursday, but chief public health officer Dr. Theresa Tam says a couple dozen possible cases are being investigated and the federal public health agency still does not know how widespread it might be.

Monkeypox is typically milder but in the same family of viruses as the now-eradicated smallpox, and can cause fever, headache, muscle aches, exhaustion, swollen lymph nodes and lesions.

The Public Health Agency of Canada says it is spread through prolonged close contact, including through direct contact with an infected person's respiratory droplets, bodily fluids or sores, and is not very contagious in a typical social setting.

There is global evidence that smallpox vaccines can offer protection against monkeypox, and Tam says Canada does maintain a small stockpile of doses in case of a biological incident.

Canada stopped routinely immunizing people against smallpox in 1972 and deputy chief public health officer Dr. Howard Njoo says that has left most people susceptible to monkeypox.

MORE National ARTICLES

Three People Charged for Keeping an Illegal Gaming House

Three People Charged for Keeping an Illegal Gaming House
Evidence gathered indicated that the Vancouver residence was being rented for the purpose of setting up and operating an alleged illegal gaming establishment.

Three People Charged for Keeping an Illegal Gaming House

Ukrainians can now apply for 3-year stay in Canada

Ukrainians can now apply for 3-year stay in Canada
The federal government has begun accepting applications from Ukrainians and their families fleeing Russian aggression who want to come to Canada while they decide their next steps. The program to allow an unlimited number of Ukrainians to come to Canada was first announced two weeks ago.

Ukrainians can now apply for 3-year stay in Canada

Gov. Gen. Simon requested briefing on Indian Act

Gov. Gen. Simon requested briefing on Indian Act
Canada's first Indigenous Governor General, within months of being appointed to the role, requested government officials outline what departments were doing to allow First Nations to move away from the Indian Act. Mary Simon, an Inuk leader, diplomat and negotiator, was sworn in last July as the country's 30th Governor General.

Gov. Gen. Simon requested briefing on Indian Act

Class action against RCMP for bullying to proceed

Class action against RCMP for bullying to proceed
The Supreme Court of Canada will not hear an appeal from the federal government trying to stop a class action against the RCMP over bullying and harassment. Last fall the Federal Court of Appeal upheld a judge's order certifying the class action.

Class action against RCMP for bullying to proceed

Vaccinated travellers won't need COVID-19 test to enter Canada as of April 1

Vaccinated travellers won't need COVID-19 test to enter Canada as of April 1
 The change is being made at the tail end of the Omicron wave in Canada, as new reported cases of COVID-19 have declined since mid-January. Duclos said the change is possible because of Canada's high vaccination rates and fewer cases of the virus being detected at the border.

Vaccinated travellers won't need COVID-19 test to enter Canada as of April 1

WHO may reject sole Canadian-made COVID-19 vaccine

WHO may reject sole Canadian-made COVID-19 vaccine
The World Health Organization says it expects to reject the COVID-19 vaccine candidate from Canada's Medicago because of the company's ties to big tobacco. The two-dose Medicago Covifenz vaccine was authorized in Canada last month for adults between 18 and 64 years old.

WHO may reject sole Canadian-made COVID-19 vaccine